| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 08/24/2006 | WO2006088711A1 AZOLYLACYLGUANIDINES AS β-SECRETASE INHIBITORS |
| 08/24/2006 | WO2006088694A1 SUBSTITUTED THIENYL AND FURYL ACYLGUANIDINES AS β-SECRETASE MODULATORS |
| 08/24/2006 | WO2006088193A1 Anti-tumor agent |
| 08/24/2006 | WO2006035067A3 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 08/24/2006 | WO2004094374A3 Preparation of (s)-clopidogrel and related compounds |
| 08/24/2006 | US20060189810 Novel sulfonamide inhibitors of aspartyl protease |
| 08/24/2006 | US20060189805 Characterized by the formation and isolation of intermediate compounds in salified form; by using the intermediate of the present process in the subsequent reductive passage, it is possible to obtain emtricitabine in a purity that allows its direct crystallization; viricides |
| 08/24/2006 | US20060189681 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 08/24/2006 | US20060189676 Pyrrolcarboxamides and Pyrrolcarbothioamides |
| 08/24/2006 | US20060189674 Deacetylase inhibitors |
| 08/24/2006 | US20060189672 2-Heterocyclyl- indole, pyrrolopyridine, pyrrolopyrimidine, or pyrrolopirazine substituted with an N-(amino)sulfonyl(thio)carboxamide: 3-Cyclohexyl-2-furan-3-yl-7-methyl-1H-indole-6-(N-methylsulfonyl)carboxamide; treating a hepatitis virus infection |
| 08/24/2006 | US20060189629 N-(2-morpholin-4-ylethyl)-1-(4-{[4-(trifluoromethoxy)benzyl]oxy}phenyl)-1H -benzimidazole-5-carboxamide; c-Kit proto-oncogene (stem cell factor receptor) anhibitor; tyrosine kinase inhibitor; antiproliferative, anticarcinogenic agent; |
| 08/24/2006 | US20060189623 5-Cyano-1H-imidazole-2-carboxylic acid [4-(3,6-dihydro-2H-pyran-4-yl)-2-(4,4-dimethyl-cyclohex-1-enyl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent |
| 08/24/2006 | US20060189622 Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations |
| 08/24/2006 | US20060189614 preparing 4-[[4-amino-6-[(2,6-dichlorophenyl)methyl]-1,3,5-triazin-2-yl]amino]benzonitrile by reacting 2,6-dichlorobenzeneethanimidamide with phenyl N'-cyano-N-(4-cyanophenyl)-carbamimidate in a reaction-inert solvent; HIV (Human Immunodeficiency Virus) infection |
| 08/24/2006 | US20060189613 Sulphonamide Compounds that Modulate Chemokine Receptor Activity (CCR4) |
| 08/24/2006 | US20060189577 Tyrosine kinase inhibitors |
| 08/24/2006 | US20060189549 Chalcone derivatives and their use to treat diseases |
| 08/24/2006 | CA2599046A1 Antitumor agent |
| 08/24/2006 | CA2598897A1 Fungicidal pyrazine derivatives |
| 08/24/2006 | CA2598460A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | CA2597594A1 Azolylacylguanidines as beta-secretase inhibitors |
| 08/23/2006 | EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists |
| 08/23/2006 | EP1693365A1 Inhibitors of dipeptidyl peptidase IV |
| 08/23/2006 | EP1692124A1 Biaryl sulfonamides as mmp inhibitors |
| 08/23/2006 | EP1692114A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 08/23/2006 | EP1692113A1 Aryl imidazoles and their use as anti-cancer agents |
| 08/23/2006 | EP1692111A2 Quinolines useful in treating cardiovascular disease |
| 08/23/2006 | EP1692085A2 Inhibition of fgfr3 and treatment of multiple myeloma |
| 08/23/2006 | EP1691810A1 Substituted piperazines |
| 08/23/2006 | EP1438349B1 Triarylamine containing monomers for optoelectronic devices |
| 08/23/2006 | EP1345907B1 7-heterocyclyl quinoline and thieno 2,3-b|pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 08/23/2006 | EP1337529B1 Heterocyclylalkyl piperidine derivatives, their preparation and compositions containing same |
| 08/23/2006 | EP1051405B1 Novel dihydroxyhexanoic acid derivatives |
| 08/23/2006 | EP1027328B1 Substituted anilides |
| 08/23/2006 | CN1823063A Quinoline derivatives as phosphodiesterase inhibitors |
| 08/23/2006 | CN1823062A Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands |
| 08/23/2006 | CN1823056A Trisubstituted aryl and heteroaryl derivatives as modulatorsof metabolism and the prophylaxis and treatment of disorders related thereto |
| 08/23/2006 | CN1823046A Phenyl quinolines and their use as estrogenic agents |
| 08/23/2006 | CN1271069C Diepoxy group containing thioxanthone photoinitiator and preparation method therefor |
| 08/23/2006 | CN1271066C Aromatic dicarboxylic acid derivatives |
| 08/23/2006 | CN1271054C Urea compounds having muscarinic receptor antagonist activity |
| 08/23/2006 | CN1271052C Sulphonamide derivatives, the preparation thereof and the application of same as medicaments |
| 08/22/2006 | US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 08/22/2006 | US7094909 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 08/22/2006 | US7094807 Viricides; hepatitis virus |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094788 A tropane ester derivative for treating asthma, chronic obstractive pulmonary disease, vagally induced sinus bradycardia, heart rhythm disorders, spasms in the gastrointestinal or urinary tracts, and menstrual pain |
| 08/22/2006 | US7094781 Sulfamides and their use as endothelin receptor antagonists |
| 08/22/2006 | US7094780 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/22/2006 | US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders. |
| 08/22/2006 | US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction |
| 08/22/2006 | US7094777 5-HT2A receptor ligands |
| 08/22/2006 | CA2242102C Quinazoline derivatives as antitumor agents |
| 08/17/2006 | WO2006086705A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
| 08/17/2006 | WO2006086657A1 Process for preparing 2,3-disubstituted indoles |
| 08/17/2006 | WO2006085113A2 2-substituted 5-membered heteroaryl carboxylates as hm74a receptor agonists |
| 08/17/2006 | WO2006085067A1 Atm inhibitors |
| 08/17/2006 | WO2006076646A3 Heteroaryl substituted quinolin-4-ylamine analogues |
| 08/17/2006 | WO2006066950A3 Tricyclic aminoalcohols, methods for producing the same and their use as anti-inflammatory agents |
| 08/17/2006 | WO2006055734A3 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 08/17/2006 | WO2006028977A3 Chiral spiro compounds and their use in asymmetric catalytic reactions |
| 08/17/2006 | US20060183908 Heterocyclic compounds, methods of making them and their use in therapy |
| 08/17/2006 | US20060183905 Derivatives of 4-(thio-or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
| 08/17/2006 | US20060183899 Having a predominantly cis configuration by coupling an S-oxide of a 2-oxymethyl- thiolane, dithiolane or oxathiolane with a nucleoside base in the presence of a tertiary amine, a Lewis acid of a Group 1B or 2B metal catalyst and deprotecting the intermediate formed |
| 08/17/2006 | US20060183791 Substituted p-diaminobenzene derivatives |
| 08/17/2006 | US20060183785 For the treatment of pain; epilepsy, manic depression, bipolar disorder, depression, anxiety and diabetic neuropathy; 5-Methyl-1-[2'-(trifluoromethoxy)-1,1'-biphenyl-3-yl]-1H-pyrazole-3-carboxamide |
| 08/17/2006 | US20060183784 Human growth hormone antagonists |
| 08/17/2006 | US20060183762 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/17/2006 | US20060183752 Process for preparing 2, 3-disubstituted indoles |
| 08/17/2006 | US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 08/17/2006 | US20060183736 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 08/17/2006 | US20060183732 Novel lactams and uses thereof |
| 08/17/2006 | CA2598429A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists |
| 08/17/2006 | CA2597680A1 Process for preparing 2,3-disubstituted indoles |
| 08/16/2006 | EP1691586A1 Charge-transporting organic material containing compound having 1,4-dithiin ring |
| 08/16/2006 | EP1690854A1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 08/16/2006 | EP1689744A1 Antiresorptive mutual salt of raloxifene and bisphosphonic acid |
| 08/16/2006 | EP1689743A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 08/16/2006 | EP1689729A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 08/16/2006 | EP1689722A2 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
| 08/16/2006 | EP1689720A1 Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 08/16/2006 | EP1689712A1 4-phenylpiperidine derivatives as renin inhibitors |
| 08/16/2006 | EP1689710A1 Indole derivatives for use as chemical uncoupler |
| 08/16/2006 | EP1689403A2 Heteroaryl-hydrazone compounds |
| 08/16/2006 | EP1689394A1 Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
| 08/16/2006 | EP1487437B1 Use of selective ep4 receptor agonists for the treatment of diseases |
| 08/16/2006 | EP1432702B1 Nitrogen-containing heterocyclic compounds and their use as raf inhibitors |
| 08/16/2006 | EP1368320B1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 08/16/2006 | EP1337247B1 Use of Gaboxadol for the treatment of premenstrual disorder, postnatal depression or postmenopausal related dysphoric disorder |
| 08/16/2006 | EP1261603B1 Flavone derivatives, preparation method and use as medicines |
| 08/16/2006 | CN1820005A Photochromic diarylethene-containing coordination compounds and the production thereof |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/16/2006 | CN1269801C Amino acid derivatives and drug containing the same as the active ingredient |
| 08/15/2006 | US7091353 Isoindole-imide compounds, compositions, and uses thereof |
| 08/15/2006 | US7091343 Compositions useful as inhibitors of protein kinases |
| 08/15/2006 | US7091247 urotensin antagonists; vasoactive agents |
| 08/15/2006 | US7091238 substiuted with 3,4-methylenedioxybenzene; treating congestive heart failure and muscle fatigue; nontoxic |
| 08/15/2006 | US7091237 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors |
| 08/15/2006 | US7091234 Thio-oxindole derivatives |